Skip to main content
Benjamin Djulbegovic, MD, Hematology, Charleston, SC

BenjaminDjulbegovicMD

Hematology Charleston, SC

Professor, MUSC

Dr. Djulbegovic is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Djulbegovic's full profile

Already have an account?

  • Office

    MUSC Hematology Oncology
    39 Sabin St, MSC 635
    Charleston, SC 29425
    Phone+1 843-792-2646
    Fax+1 843-792-0644

Education & Training

  • University of Louisville School of Medicine
    University of Louisville School of MedicineFellowship, Hematology and Medical Oncology, 1988 - 1991
  • University of Sarajevo FOM
    University of Sarajevo FOMClass of 1976
  • University of Louisville School of Medicine
    University of Louisville School of MedicineResidency, Internal Medicine

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 1998 - 2026
  • CA State Medical License
    CA State Medical License 2017 - 2025
  • IN State Medical License
    IN State Medical License 1994 - 2025
  • KY State Medical License
    KY State Medical License 1990 - 2025
  • SC State Medical License
    SC State Medical License 2023 - 2025
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2009-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013

Publications & Presentations

PubMed

Journal Articles

  • Evaluation of Daratumumab for the Treatment of Multiple Myeloma in Patients with High-Risk Cytogenetic Factors  
    Susan Bal, Benjamin Djulbegovic, Saad Z Usmani, JAMA Oncology
  • Bisphosphonates for Patients Diagnosed with Multiple Myeloma  
    Benjamin Djulbegovic, MD, JAMA

Lectures

  • The Influence of Activity Roles and Use of a Structured Framework on Developing Hematology Clinical Practice Guidelines 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • New Report Assesses COVID-19’S Trajectory and Implications for Medicare, Social Security
    New Report Assesses COVID-19’S Trajectory and Implications for Medicare, Social SecurityJune 3rd, 2021
  • Use of a Decision Tree and Omics Data May Help Improve Survival Rates in Advanced NSCLC
    Use of a Decision Tree and Omics Data May Help Improve Survival Rates in Advanced NSCLCSeptember 2nd, 2020
  • US Food and Drug Administration Approvals of Drugs and Devices Based on Nonrandomized Clinical Trials
    US Food and Drug Administration Approvals of Drugs and Devices Based on Nonrandomized Clinical TrialsSeptember 11th, 2019
  • Join now to see all

Committees

  • Member, Expert Panel, AABB 2015 - Present

Professional Memberships